Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto (Q35568485)
Jump to navigation
Jump to search
scientific article published on 16 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto |
scientific article published on 16 January 2015 |
Statements
1 reference
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto (English)
1 reference
Ritsuko Komaki
1 reference
George Blumenschein
1 reference
Jeffrey D Bradley
1 reference
Rebecca Paulus
1 reference
Gregory Masters
1 reference
Steven Schild
1 reference
Jeffrey Bogart
1 reference
Kenneth Forster
1 reference
Anthony Magliocco
1 reference
Vivek Kavadi
1 reference
Yolanda I Garces
1 reference
Samir Narayan
1 reference
Puneeth Iyengar
1 reference
Christopher Koprowski
1 reference
Joanne Meng
1 reference
Jonathan Beitler
1 reference
Rakesh Gaur
1 reference
Walter Curran
1 reference
Hak Choy
1 reference
16 January 2015
1 reference
1 reference
16
1 reference
2
1 reference
187-199
1 reference
Identifiers
1 reference
1 reference
1 reference